Table 2.
Seroprevalence of anti-HEV antibodies in Korea according to sex, age, and residency
| Variables | Total number (%) | Number of anti-HEV IgG positives (%) | Odds ratio (95% CI)a | p |
|---|---|---|---|---|
| Sex | ||||
| Male | 239 (48.88) | 26 (10.88) | 1 | 0.2757 |
| Female | 250 (51.12) | 20 (8.00) | 0.71 (0.39, 1.31) | |
| Age groups | ||||
| 10–14 | 118 (24.13) | 1 (0.85) | 1 | <0.0001 |
| 15–19 | 78 (15.95) | 0 (0.00) | – | |
| 20–29 | 96 (19.63) | 5 (5.21) | 6.43(0.74, 55.99) | |
| 30–39 | 98 (20.04) | 7 (7.14) | 9.00 (1.09, 74.47) | |
| 40–59 | 65 (13.29) | 15 (23.08) | 35.10 (4.51, 272.97) | |
| ≥60 | 34 (6.95) | 18 (52.94) | 131.63 (16.44, 148.07) | |
| Residency | ||||
| Urban | 201 (41.10) | 18 (8.96) | 1 | 0.0003 |
| Suburban | 234 (47.85) | 15 (6.41) | 0.70 (0.34, 1.42) | |
| Rural | 54 (11.04) | 13 (24.07) | 3.22 (1.46, 7.10) | |
Odds ratio to have HEV antibioses by sex, age group and residency Calculated by χ2 test.
HEV = hepatitis E virus.
a
CI = confidence interval; 1 = referent.